Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Nature Communications|April 15, 2020
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axisCristina Morales Torres, Mary Y Wu, Sebastijan Hobor, et al.
Journal for Immunotherapy of Cancer|August 16, 2017
The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironmentEdmund Poon, Stefanie Mullins, Amanda Watkins, et al.
Cell Metabolism|December 3, 2015
Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal CancerAurélien J C Pommier, Matthew Farren, Bhavika Patel, et al.
Cancer Research|August 18, 2018
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547Sjors M Kas, Julian R de Ruiter, Koen Schipper, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 19, 2013
English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2James R Tysome, Patrick R Axon, Neil P Donnelly, et al.
Neuro-Oncology Advances|April 13, 2023
Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progressionD Gareth Evans, Dorothy Halliday, Rupert Obholzer, et al.
International Journal of Environmental Research and Public Health|August 5, 2017
Regional Assessment of Human Fecal Contamination in Southern California Coastal DrainagesYiping Cao, Meredith R Raith, Paul D Smith, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 14, 2026
A systematic review and Meta-Analysis ofMiddle meningeal artery embolization for Non-Acute Subdural Haematoma: A proposed treatment algorithmJack Edward Liu, Christen D Barras, Behnam Shaygi, et al.
Clinical and Translational Science|November 26, 2015
Team Science Approach to Developing Consensus on Research Good Practices for Practice-Based Research Networks: A Case StudyKimberly Campbell-Voytal, Jeanette M Daly, Zsolt J Nagykaldi, et al.
Nature Communications|May 4, 2019
MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAFV600E amplification whereas KRASG13D amplification promotes EMT-chemoresistanceMatthew J Sale, Kathryn Balmanno, Jayeta Saxena, et al.
Pageof 22